Photodynamic Therapy With Verteporfin and Intravitreal Triamcinolone Acetonide in the Treatment of Neovacular Age-related Macular Degeneration Original Reearch Article

Purpoe To examine the efficacy of photodynamic therapy (PDT) with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovacular age-related macular degeneration (AMD). Deign Retropective, interventional cae erie. Method ixty eye of 56 patient with neovacular AMD were treated with PDT with verteporfin followed by an intravitreal injection of 4 mg triamcinolone acetonide. The main outcome meaure were viual acuity (VA), retreatment frequency with PDT (and triamcinolone), and frequency of ide effect. Reult Mean follow-up wa 15.9 month (range 12 to 30 month, median 15 month). Twenty-three (38.3%) of 60 eye had a table reult at 12 month’ follow-up (that i, lo/gain